You have 9 free searches left this month | for more free features.

Overall Status

Recruiting (15)

Not yet recruiting (5)

Active, not recruiting (3)

Completed (2)

Terminated (2)

Unknown status (1)

Sign in for free

Phase

phase 2 (14)

phase 1 (4)

phase 3 (4)

phase 1/phase 2 (2)

phase 2/phase 3 (2)

n/a (1)

Study Documents

Intervention Type

drug (28)

radiation (8)

procedure (4)

biological (2)

device (2)

other (2)

Funder Type

Other (23)

Industry (5)

Study Type

Interventional (27)

Observational (1)

mfolfirinox

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pancreatic Cancer, Pancreatic Carcinoma Non-resectable Trial in United States (drug, biological, radiation)

Terminated

Pancreatic Cancer
Pancreatic Carcinoma Non-resectable

mFOLFIRINOX
+3 more

Louisville, Kentucky
+3 more

May 26, 2020

Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemo Trial in Hangzhou (AG regimen, mFolfirinox)

Recruiting

Pancreatic Adenocarcinoma Resectable
Neoadjuvant Chemotherapy

AG regimen
mFolfirinox

Hangzhou, Zhejiang, China

The second affiliated hospital of Zhejiang University

Nov 20, 2018

Borderline Resectable Pancreatic Cancer Trial in Pittsburgh (gemcitabine/nab-paclitaxel, mFOLFIRINOX)

Terminated

Borderline Resectable Pancreatic Cancer

gemcitabine/nab-paclitaxel
mFOLFIRINOX

Pittsburgh, Pennsylvania

Hillman Cancer Center

Jun 30, 2018